• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸膜外全肺切除术后恶性胸膜间皮瘤的质子治疗。

Proton therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy.

机构信息

Department of Radiation Oncology, Zurich University Hospital, Switzerland.

出版信息

Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):628-34. doi: 10.1016/j.ijrobp.2009.11.006. Epub 2010 Apr 10.

DOI:10.1016/j.ijrobp.2009.11.006
PMID:20385451
Abstract

PURPOSE

To perform comparative planning for intensity-modulated radiotherapy (IMRT) and proton therapy (PT) for malignant pleural mesothelioma after radical surgery.

METHODS AND MATERIALS

Eight patients treated with IMRT after extrapleural pleuropneumonectomy (EPP) were replanned for PT, comparing dose homogeneity, target volume coverage, and mean and maximal dose to organs at risk. Feasibility of PT was evaluated regarding the dose distribution with respect to air cavities after EPP.

RESULTS

Dose coverage and dose homogeneity of the planning target volume (PTV) were significantly better for PT than for IMRT regarding the volume covered by >95% (V95) for the high-dose PTV. The mean dose to the contralateral kidney, ipsilateral kidney, contralateral lung, liver, and heart and spinal cord dose were significantly reduced with PT compared with IMRT. After EPP, air cavities were common (range, 0-850 cm(3)), decreasing from 0 to 18.5 cm(3)/day. In 2 patients, air cavity changes during RT decreased the generalized equivalent uniform dose (gEUD) in the case of using an a value of < - 10 to the PTV2 to <2 Gy in the presence of changing cavities for PT, and to 40 Gy for IMRT. Small changes were observed for gEUD of PTV1 because PTV1 was reached by the beams before air.

CONCLUSION

Both PT and IMRT achieved good target coverage and dose homogeneity. Proton therapy accomplished additional dose sparing of most organs at risk compared with IMRT. Proton therapy dose distributions were more susceptible to changing air cavities, emphasizing the need for adaptive RT and replanning.

摘要

目的

为根治性手术后恶性胸膜间皮瘤行调强放疗(IMRT)和质子治疗(PT)进行对比规划。

方法与材料

对 8 例行胸膜外全肺切除术(EPP)后行 IMRT 的患者进行 PT 再规划,比较剂量均匀性、靶区覆盖、危及器官的平均剂量和最大剂量。根据 EPP 后空气腔的剂量分布评估 PT 的可行性。

结果

PT 覆盖高剂量 PTV 的 V95 体积比 IMRT 显著更好,PT 规划靶区(PTV)的剂量覆盖和均匀性明显更好。与 IMRT 相比,PT 可显著降低对侧肾脏、同侧肾脏、对侧肺、肝脏、心脏和脊髓剂量的平均剂量。EPP 后,空气腔很常见(范围 0-850cm3),每天减少 0-18.5cm3。在 2 例患者中,由于空气腔变化,在使用 < - 10 的 a 值时,PT 中 PTV2 的广义等效均匀剂量(gEUD)降至 <2Gy,而 IMRT 则降至 40Gy。由于空气腔的存在,PTV1 中 gEUD 变化较小,因为光束先到达 PTV1 再到达空气腔。

结论

PT 和 IMRT 均能达到良好的靶区覆盖和剂量均匀性。与 IMRT 相比,质子治疗能进一步保护大多数危及器官的剂量。质子治疗剂量分布更容易受到空气腔变化的影响,这强调了自适应放疗和重新规划的必要性。

相似文献

1
Proton therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy.胸膜外全肺切除术后恶性胸膜间皮瘤的质子治疗。
Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):628-34. doi: 10.1016/j.ijrobp.2009.11.006. Epub 2010 Apr 10.
2
Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.胸膜肺切除术后联合光子和电子三维适形放疗与调强放疗并同步加量辅助治疗恶性胸膜间皮瘤
Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1593-9. doi: 10.1016/j.ijrobp.2007.07.2370. Epub 2007 Oct 10.
3
Intensity-modulated radiotherapy and volumetric-modulated arc therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy.胸膜外全肺切除术后恶性胸膜间皮瘤的调强放疗和容积旋转调强放疗。
J Appl Clin Med Phys. 2013 Jul 8;14(4):4130. doi: 10.1120/jacmp.v14i4.4130.
4
Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.调强放疗治疗恶性胸膜间皮瘤中增加经验对剂量学和临床结果的影响。
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):362-8. doi: 10.1016/j.ijrobp.2011.11.057.
5
Restricted field IMRT dramatically enhances IMRT planning for mesothelioma.受限野调强放疗显著改善间皮瘤的调强放疗计划。
Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1587-92. doi: 10.1016/j.ijrobp.2007.06.075. Epub 2007 Sep 24.
6
Compensator-based intensity-modulated radiation therapy for malignant pleural mesothelioma post extrapleural pneumonectomy.基于补偿器的调强放射治疗在胸膜外全肺切除术后恶性胸膜间皮瘤中的应用
J Appl Clin Med Phys. 2008 Oct 29;9(4):98-109. doi: 10.1120/jacmp.v9i4.2799.
7
Evaluating target coverage and normal tissue sparing in the adjuvant radiotherapy of malignant pleural mesothelioma: helical tomotherapy compared with step-and-shoot IMRT.评估恶性胸膜间皮瘤辅助放疗中的靶区覆盖和正常组织保护:螺旋断层放疗与静态调强放疗的比较
Radiother Oncol. 2008 Feb;86(2):251-7. doi: 10.1016/j.radonc.2007.12.010. Epub 2008 Jan 18.
8
Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer.质子治疗为接受胰头癌术后放疗的患者提供了较低的正常组织照射。
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):158-63. doi: 10.1016/j.ijrobp.2011.05.045. Epub 2012 Jan 13.
9
Volumetric modulation arc radiotherapy compared with static gantry intensity-modulated radiotherapy for malignant pleural mesothelioma tumor: a feasibility study.容积调强弧形放疗与静态机架调强放疗治疗恶性胸膜间皮瘤肿瘤的比较:一项可行性研究。
Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):942-9. doi: 10.1016/j.ijrobp.2009.09.053. Epub 2010 Apr 8.
10
Tomotherapy in malignant mesothelioma: a planning study to establish dose constraints.恶性间皮瘤中的调强放疗:建立剂量约束的计划研究。
Strahlenther Onkol. 2019 Jul;195(7):668-676. doi: 10.1007/s00066-019-01458-1. Epub 2019 Mar 26.

引用本文的文献

1
Assessment of Proton Beam Therapy Use Among Patients With Newly Diagnosed Cancer in the US, 2004-2018.美国 2004-2018 年新发癌症患者质子束治疗使用评估。
JAMA Netw Open. 2022 Apr 1;5(4):e229025. doi: 10.1001/jamanetworkopen.2022.9025.
2
GOECP/SEOR clinical guidelines on radiotherapy for malignant pleural mesothelioma.GOECP/SEOR 恶性胸膜间皮瘤放射治疗临床指南
World J Clin Oncol. 2021 Aug 24;12(8):581-608. doi: 10.5306/wjco.v12.i8.581.
3
Cardiotoxicity of mediastinal radiotherapy.纵隔放疗的心脏毒性
Rep Pract Oncol Radiother. 2019 Nov-Dec;24(6):629-643. doi: 10.1016/j.rpor.2019.09.002. Epub 2019 Oct 30.
4
Impact of aeration change and beam arrangement on the robustness of proton plans.通气变化和射束排列对质子治疗计划稳健性的影响
J Appl Clin Med Phys. 2019 Mar;20(3):14-21. doi: 10.1002/acm2.12503. Epub 2019 Feb 12.
5
A Novel Prospective Study Assessing the Combination of Photodynamic Therapy and Proton Radiation Therapy: Safety and Outcomes When Treating Malignant Pleural Mesothelioma.一项评估光动力疗法联合质子放射治疗恶性胸膜间皮瘤的安全性和疗效的前瞻性研究。
Photochem Photobiol. 2019 Jan;95(1):411-418. doi: 10.1111/php.13065. Epub 2018 Dec 28.
6
Proton beam therapy for malignant pleural mesothelioma.质子束疗法治疗恶性胸膜间皮瘤。
Transl Lung Cancer Res. 2018 Apr;7(2):189-198. doi: 10.21037/tlcr.2018.04.07.
7
Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.恶性胸膜间皮瘤的治疗:美国临床肿瘤学会临床实践指南。
J Clin Oncol. 2018 May 1;36(13):1343-1373. doi: 10.1200/JCO.2017.76.6394. Epub 2018 Jan 18.
8
Heart Dosimetry is Correlated With Risk of Radiation Pneumonitis After Lung-Sparing Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma.对于恶性胸膜间皮瘤,在保留肺的半胸胸膜调强放射治疗后,心脏剂量测定与放射性肺炎风险相关。
Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):61-69. doi: 10.1016/j.ijrobp.2017.04.025. Epub 2017 Apr 27.
9
Does selective pleural irradiation of malignant pleural mesothelioma allow radiation dose escalation? : A planning study.恶性胸膜间皮瘤的选择性胸膜照射能否提高放射剂量?:一项计划研究。
Strahlenther Onkol. 2017 Apr;193(4):285-294. doi: 10.1007/s00066-017-1108-y. Epub 2017 Feb 14.
10
Clinical experience of volumetric modulated arc therapy for malignant pleural mesothelioma after extrapleural pneumonectomy.胸膜外全肺切除术后容积调强弧形放疗治疗恶性胸膜间皮瘤的临床经验
J Radiat Res. 2015 Mar;56(2):315-24. doi: 10.1093/jrr/rru102. Epub 2015 Jan 18.